Review



macsplex buffer  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Miltenyi Biotec macsplex buffer
    Macsplex Buffer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/mac+buf/pm36577715-66-9-24
    Average 90 stars, based on 1 article reviews
    macsplex buffer - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Production cell analysis and compound-based boosting of small extracellular vesicle secretion using a generic and scalable production platform.
    Article Snippet: Funding information Bundesministerium für Bildung und Forschung Abstract Extracellular vesicles (EVs) are a novel format of advanced therapeutical medicinal products (ATMPs).. They can act regenerative or immune‐modulatory as cell therapy substitutes or as a platform for designer exosomes.. The biotechnological production of therapeutic EVs is still very much uncharted territory so standardized host cells, production setups, and isolation methods are not yet implemented.

    Flow Cytometry:

    Article Title: Engineering of extracellular vesicles for display of protein biotherapeutics
    Article Snippet: For counterstaining of captured EVs, either a mixture of APC-conjugated anti-CD9, anti-CD63 and anti-CD81 detection antibodies (supplied in the MACSPlex kit, 5 μ l each) or anti-decoy receptor antibodies (AlexaFluor647-labelled anti-human TNFR1, Bio-Rad, cat #MCA1340A647, clone H398, lot 0410; or APC-labelled anti-mouse gp130, R&D Systems, cat #FAB4681A, clone 125623, lot AAOK0114071; 200 ng, respectively) were added to each well in a total volume of 135 μ l and the plate was incubated at 450 g for 1 hours at room temperature. .. Next, the samples were washed twice, resuspended in MACSPlex buffer and analyzed by flow cytometry with a MACSQuant Analyzer 10 flow cytometer (Miltenyi Biotec). .. FlowJo software (version 10.6.2, FlowJo, LLC) was used to analyze flow cytometric data.



    Similar Products

    macsplex buffer  (Thermo Fisher)
    86
    Thermo Fisher macsplex buffer
    Macsplex Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/pmc11385381-86-9-20
    Average 86 stars, based on 1 article reviews
    macsplex buffer - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    macsplex buffer  (Miltenyi Biotec)
    90
    Miltenyi Biotec macsplex buffer
    Macsplex Buffer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/mac+buf/pm36577715-66-9-24
    Average 90 stars, based on 1 article reviews
    macsplex buffer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    in macsplex buffer  (Exosome Diagnostics)
    90
    Exosome Diagnostics in macsplex buffer
    In Macsplex Buffer, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/in+macsplex+buffer/pm38242057-83-19-15
    Average 90 stars, based on 1 article reviews
    in macsplex buffer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    macsplex buffer  (Becton Dickinson)
    90
    Becton Dickinson macsplex buffer
    Macsplex Buffer, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/macsplex+buffer/pm38054812-143-10-20
    Average 90 stars, based on 1 article reviews
    macsplex buffer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    macsplex buffer buffer  (Thermo Fisher)
    90
    Thermo Fisher macsplex buffer buffer
    Macsplex Buffer Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/pmc09206228-99-8-19
    Average 90 stars, based on 1 article reviews
    macsplex buffer buffer - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    macsplex buffer (mbp  (Millipore)
    90
    Millipore macsplex buffer (mbp
    Differential centrifugation of whole blood efficiently separates different cell and vesicle populations. (a) Schematic of the differential centrifugation protocol used to separate red (RBC) and white blood cells (WBC), platelets (PL), apoptotic bodies (AB), large (LEV) and small extracellular vesicles (SEV), as well as soluble protein (SP) and flow through (FT). (b) Representative transmission electron microscopy images of vesicles enriched in AB, LEV and SEV fractions. Corresponding scale bars are inset. (c) Representative Western blots of blood components for histone H3 (H3), CD42A, cleaved Caspase 9 (CASP9), BAX, CD9 and CD81. A CD9 blotted membrane with vesicular and SP components was additionally overexposed. Molecular weight is indicated beside each blot. (d) Nanoparticle tracking analysis data showing the concentration of particles/ml at sizes ranging from 0–1 μm in LEV, SEV and SP fractions. Inset is a quantification of the concentration of particles from 400–600 nm found in each fraction. (d) Median CD9/63/81 fluorescence for 35 capture antibody coated beads from the <t>MACSplex</t> vesicle surface protein flow cytometry assay in the different blood components. The platelet fraction was diluted 1:10 before analysis
    Macsplex Buffer (Mbp, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/macs+buffer/pmc08485184-68-8-30
    Average 90 stars, based on 1 article reviews
    macsplex buffer (mbp - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    macsplex buffer solution  (Miltenyi Biotec)
    98
    Miltenyi Biotec macsplex buffer solution
    Figure 1. Plasma <t>and</t> <t>CSF</t> preparation for <t>MACSPlex</t> human Exosome assay. (a) Protocol for extracellular vesicle (EV) enrichment and characterization by MACSPlex Exosome Assay. Blood and cerebrospinal fluid (CSF) underwent serial centrifugation to eliminate cellular components and larger EVs. Samples were incubated overnight with phycoerythrin (PE)- and fluorescein isothiocyanate (FITC)-labeled capture beads, coated with antibodies against 37 different EV surface markers. APC-conjugated detection antibodies against CD9, CD63, and CD81 were added and incubated for 1 h. After washing steps, samples were analyzed by flow cytometry. (b) Schematic representation of the 37 EV surface markers analyzed by MACSPlex human Exosome assay.
    Macsplex Buffer Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+buffer/MACSQuant+Analyzer+10/pm33669043-62-16-30
    Average 98 stars, based on 1 article reviews
    macsplex buffer solution - by Bioz Stars, 2026-10
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    Differential centrifugation of whole blood efficiently separates different cell and vesicle populations. (a) Schematic of the differential centrifugation protocol used to separate red (RBC) and white blood cells (WBC), platelets (PL), apoptotic bodies (AB), large (LEV) and small extracellular vesicles (SEV), as well as soluble protein (SP) and flow through (FT). (b) Representative transmission electron microscopy images of vesicles enriched in AB, LEV and SEV fractions. Corresponding scale bars are inset. (c) Representative Western blots of blood components for histone H3 (H3), CD42A, cleaved Caspase 9 (CASP9), BAX, CD9 and CD81. A CD9 blotted membrane with vesicular and SP components was additionally overexposed. Molecular weight is indicated beside each blot. (d) Nanoparticle tracking analysis data showing the concentration of particles/ml at sizes ranging from 0–1 μm in LEV, SEV and SP fractions. Inset is a quantification of the concentration of particles from 400–600 nm found in each fraction. (d) Median CD9/63/81 fluorescence for 35 capture antibody coated beads from the MACSplex vesicle surface protein flow cytometry assay in the different blood components. The platelet fraction was diluted 1:10 before analysis

    Journal: Journal of Extracellular Vesicles

    Article Title: Extracellular vesicles are the primary source of blood‐borne tumour‐derived mutant KRAS DNA early in pancreatic cancer

    doi: 10.1002/jev2.12142

    Figure Lengend Snippet: Differential centrifugation of whole blood efficiently separates different cell and vesicle populations. (a) Schematic of the differential centrifugation protocol used to separate red (RBC) and white blood cells (WBC), platelets (PL), apoptotic bodies (AB), large (LEV) and small extracellular vesicles (SEV), as well as soluble protein (SP) and flow through (FT). (b) Representative transmission electron microscopy images of vesicles enriched in AB, LEV and SEV fractions. Corresponding scale bars are inset. (c) Representative Western blots of blood components for histone H3 (H3), CD42A, cleaved Caspase 9 (CASP9), BAX, CD9 and CD81. A CD9 blotted membrane with vesicular and SP components was additionally overexposed. Molecular weight is indicated beside each blot. (d) Nanoparticle tracking analysis data showing the concentration of particles/ml at sizes ranging from 0–1 μm in LEV, SEV and SP fractions. Inset is a quantification of the concentration of particles from 400–600 nm found in each fraction. (d) Median CD9/63/81 fluorescence for 35 capture antibody coated beads from the MACSplex vesicle surface protein flow cytometry assay in the different blood components. The platelet fraction was diluted 1:10 before analysis

    Article Snippet: Beads were washed by adding 200 μl of MACSPlex Buffer (MBP) to each well and the filter plate was put on a vacuum manifold with vacuum applied at ‐100 mBar (Sigma‐Aldrich, Germany) until all wells were drained.

    Techniques: Centrifugation, Transmission Assay, Electron Microscopy, Western Blot, Molecular Weight, Concentration Assay, Fluorescence, Flow Cytometry

    Figure 1. Plasma and CSF preparation for MACSPlex human Exosome assay. (a) Protocol for extracellular vesicle (EV) enrichment and characterization by MACSPlex Exosome Assay. Blood and cerebrospinal fluid (CSF) underwent serial centrifugation to eliminate cellular components and larger EVs. Samples were incubated overnight with phycoerythrin (PE)- and fluorescein isothiocyanate (FITC)-labeled capture beads, coated with antibodies against 37 different EV surface markers. APC-conjugated detection antibodies against CD9, CD63, and CD81 were added and incubated for 1 h. After washing steps, samples were analyzed by flow cytometry. (b) Schematic representation of the 37 EV surface markers analyzed by MACSPlex human Exosome assay.

    Journal: Biomedicines

    Article Title: Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.

    doi: 10.3390/biomedicines9030230

    Figure Lengend Snippet: Figure 1. Plasma and CSF preparation for MACSPlex human Exosome assay. (a) Protocol for extracellular vesicle (EV) enrichment and characterization by MACSPlex Exosome Assay. Blood and cerebrospinal fluid (CSF) underwent serial centrifugation to eliminate cellular components and larger EVs. Samples were incubated overnight with phycoerythrin (PE)- and fluorescein isothiocyanate (FITC)-labeled capture beads, coated with antibodies against 37 different EV surface markers. APC-conjugated detection antibodies against CD9, CD63, and CD81 were added and incubated for 1 h. After washing steps, samples were analyzed by flow cytometry. (b) Schematic representation of the 37 EV surface markers analyzed by MACSPlex human Exosome assay.

    Article Snippet: In total, 60 μL of plasma and 30 μL of ultracentrifuged CSF were added to the MACSPlex Buffer solution (final volume 120 μL) and analyzed with MACSQuant Analyzer-10 flow cytometer (Miltenyi, Bergisch Gladbach, Germany).

    Techniques: Clinical Proteomics, Centrifugation, Incubation, Labeling, Cytometry

    Figure 3. CSF-derived EVs characterization. Characterization of cerebrospinal fluid (CSF)-derived extracellular vesicles (EVs) by nanoparticle tracking analysis (NTA) and MACSPlex human exosome assay flow cytometry. Healthy controls (HC) were compared with patients with Parkinson’s disease (PD) multisystem atrophy (MSA), or atypical parkinsonism with tauopathies (AP-Tau). (a) EV concentration (n/mL CSF) at NTA. (b) EV diameter (nm) at NTA. Boxplots show median and interquartile range; bars show minimum and maximum values (* p < 0.05). (c) Normalized median fluorescence intensity (nMFI; %) for 37 EV surface markers. Data and statistics are reported in Table S1. (d,e) Different perspectives of 3D-canonical plot reporting patient discrimination according to EV surface marker expression (each patient is indicated by a point and diagnoses are represented by colors: HC, blue; PD, red; MSA, orange; AP-Tau, grey). Canonical axes of the plot (canonical components 1, 2, and 3) are defined by linear discrimination analysis from weighted linear combinations of the 37 EV markers analyzed by flow cytometry. Spheres include patients with linear combination coefficients that fall within the mean ± SD (canonicals 1, 2, and 3 ± SD).

    Journal: Biomedicines

    Article Title: Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.

    doi: 10.3390/biomedicines9030230

    Figure Lengend Snippet: Figure 3. CSF-derived EVs characterization. Characterization of cerebrospinal fluid (CSF)-derived extracellular vesicles (EVs) by nanoparticle tracking analysis (NTA) and MACSPlex human exosome assay flow cytometry. Healthy controls (HC) were compared with patients with Parkinson’s disease (PD) multisystem atrophy (MSA), or atypical parkinsonism with tauopathies (AP-Tau). (a) EV concentration (n/mL CSF) at NTA. (b) EV diameter (nm) at NTA. Boxplots show median and interquartile range; bars show minimum and maximum values (* p < 0.05). (c) Normalized median fluorescence intensity (nMFI; %) for 37 EV surface markers. Data and statistics are reported in Table S1. (d,e) Different perspectives of 3D-canonical plot reporting patient discrimination according to EV surface marker expression (each patient is indicated by a point and diagnoses are represented by colors: HC, blue; PD, red; MSA, orange; AP-Tau, grey). Canonical axes of the plot (canonical components 1, 2, and 3) are defined by linear discrimination analysis from weighted linear combinations of the 37 EV markers analyzed by flow cytometry. Spheres include patients with linear combination coefficients that fall within the mean ± SD (canonicals 1, 2, and 3 ± SD).

    Article Snippet: In total, 60 μL of plasma and 30 μL of ultracentrifuged CSF were added to the MACSPlex Buffer solution (final volume 120 μL) and analyzed with MACSQuant Analyzer-10 flow cytometer (Miltenyi, Bergisch Gladbach, Germany).

    Techniques: Derivative Assay, Cytometry, Concentration Assay, Marker, Expressing

    Figure 4. EV quantitative analysis: plasma vs. CSF. Quantitative analysis of extracellular vesicles (EVs) by nanoparticle tracking analysis (NTA) and MACSPlex assay flow cytometry; plasma samples were compared to paired cerebrospinal fluid (CSF) samples in patients with PD (Parkinson’s disease; n = 4), MSA (multisystem atrophy; n = 4) and AP-Tau (atypical parkinsonism with tauopathies; n = 4). (a) EV concentration (n/mL plasma or CSF) at NTA. (b) EV diameter (nm) at NTA. (c) MFI (expressed as arbitrary unity; a.u.) for CD9, CD63, CD81 and CD9-CD63-CD81 at flow cytometry. Boxplots show median and interquartile range; bars show minimum and maximum values (** p < 0.05; *** p < 0.001). Data and statistics are reported in Table S2.

    Journal: Biomedicines

    Article Title: Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.

    doi: 10.3390/biomedicines9030230

    Figure Lengend Snippet: Figure 4. EV quantitative analysis: plasma vs. CSF. Quantitative analysis of extracellular vesicles (EVs) by nanoparticle tracking analysis (NTA) and MACSPlex assay flow cytometry; plasma samples were compared to paired cerebrospinal fluid (CSF) samples in patients with PD (Parkinson’s disease; n = 4), MSA (multisystem atrophy; n = 4) and AP-Tau (atypical parkinsonism with tauopathies; n = 4). (a) EV concentration (n/mL plasma or CSF) at NTA. (b) EV diameter (nm) at NTA. (c) MFI (expressed as arbitrary unity; a.u.) for CD9, CD63, CD81 and CD9-CD63-CD81 at flow cytometry. Boxplots show median and interquartile range; bars show minimum and maximum values (** p < 0.05; *** p < 0.001). Data and statistics are reported in Table S2.

    Article Snippet: In total, 60 μL of plasma and 30 μL of ultracentrifuged CSF were added to the MACSPlex Buffer solution (final volume 120 μL) and analyzed with MACSQuant Analyzer-10 flow cytometer (Miltenyi, Bergisch Gladbach, Germany).

    Techniques: Clinical Proteomics, Cytometry, Concentration Assay